Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Solasto Corp. ( (JP:6197) ) has issued an update.
Solasto Corporation reported its consolidated financial results for the second quarter of FY2025, showing a modest increase in net sales by 2.4% to 70,033 million yen. However, operating profit decreased by 4.7%, while net income saw a significant rise of 21.9%. The company also announced a revision in its earnings forecast for the full fiscal year, reflecting adjustments due to a stock buyback plan. The dividend per share is forecasted to increase, indicating a positive outlook for shareholders.
The most recent analyst rating on (JP:6197) stock is a Buy with a Yen602.00 price target. To see the full list of analyst forecasts on Solasto Corp. stock, see the JP:6197 Stock Forecast page.
More about Solasto Corp.
Solasto Corporation is a company listed on the Tokyo Stock Exchange, primarily engaged in providing services in the healthcare and medical sectors. The company focuses on delivering operational support and staffing services to medical institutions, aiming to enhance efficiency and service quality in the healthcare industry.
Average Trading Volume: 262,849
Technical Sentiment Signal: Buy
Current Market Cap: Yen47.94B
For detailed information about 6197 stock, go to TipRanks’ Stock Analysis page.